Get started
Work

Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (axi-cel) in Patients with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): Real-World Practice Patterns and Outcomes

Year: 2022
Type: article
Study design: Observational Study
Source: Blood
DOI: 10.1182/blood-2022-170486
Authors: Arushi Khurana, Megumi Bailey, Madiha Iqbal, Radhika Bansal, Catherine J. Lee, Bradley Hunter, Matthew A. Lunning, Samantha Jaglowski, Michael D. Jain, Saurabh Dahiya, Veronika Bachanova, Umar Farooq, Sairah Ahmed, Brian T. Hill, Javier L. Munoz, Krish Patel, Olalekan O. Oluwole, Yi Lin
Institutions: Mayo Clinic, Swedish Medical Center, Mayo Clinic in Florida, University of Utah, Huntsman Cancer Institute, Intermountain Healthcare, LDS Hospital, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Moffitt Cancer Center, Stanford Medicine, Stanford University, University of Minnesota, University of Iowa, The University of Texas MD Anderson Cancer Center, Cleveland Clinic, Mayo Clinic in Arizona, Mayo Clinic Hospital, Vanderbilt University Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4310106257
FWCI:
Cites:
Cited by:
Related to: 10